Published in Cancer Weekly, February 2nd, 1998
Biotechnology companies gathered at the Hambrecht and Quist Healthcare Conference, held in San Diego, California, during January 1998 to discuss progress in bringing new drugs to market say some of their most promising research involves monoclonal antibodies, which are natural immune system chemicals that have been altered for use as cancer drugs.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.